Loading cancer entity…
Loading cancer entity…
Clinical trials
8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07805798 | Urinary Bladder Matrix (UBM) Registry | not yet recruiting | — | 300 | Integra LifeSciences CorporationINDUSTRY | 0 | Sep 4, 2026 | clinicaltrials |
| NCT07301424 | Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL | not yet recruiting | Phase 2 | 80 | University of AlbertaOTHER | 1 | Aug 12, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Sep 4, 2026source: clinicaltrials